Recent Finacing
Recent Raise
E25Bio develops low-cost, paper-based, nanoparticle rapid diagnostic tests and a companion mobile app for 15-minute, at-home detection and mapping of viral infections such as dengue, Zika, chikungunya, and SARS-CoV-2.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at E25Bio.
